# An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms

> **NCT01413711** · PHASE4 · WITHDRAWN · sponsor: **Lundbeck LLC**

## Conditions studied

- Infantile Spasms

## Interventions

- **DRUG:** Vigabatrin

## Key facts

- **NCT ID:** NCT01413711
- **Lead sponsor:** Lundbeck LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-06
- **Primary completion:** 2013-09
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2012-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01413711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01413711, "An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01413711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*